[1] 曾繁典,郑荣远,詹思延,等. 药物流行病学[M]//第十九章 药物流行病学的未来.北京:中国医药科技出版社, 2016: 629-632. [2] Mussen F, Salek S, Walker S. A quantitative approach to benefit-risk assessment of medicines-part 1: the development of a new model using multi-criteria decision analysis[J]. Pharmacoepidem-iology and Drug Safety, 2007(S1), 16:S2-S15. [3] Committee for Medical Products for Human Use. Benefit-risk methodology project: work package 2 report: applicability of current tools and processes for regulatory benefit-risk assessment[R]. London: European Medicines Agency, 2010:27-28. [4] 杨依晗, 马爱霞. 药品上市后效益风险评价方法综述[J]. 中国药物经济学, 2008, (6): 50-56. [5] 李姗, 许燕, 杨悦. 国外定量药品风险-效益评价方法简析[J]. 中国药物警戒, 2012, 9(5): 286-289. [6] 余漩. 基本药物制度和国家基本药物目录遴选多标准决策研究[D]. 西安: 第四军医大学, 2010. [7] 刘永军, 马林超, 刘国恩. 多指标决策分析在卫生技术评价中的应用研究[J]. 中国药物经济学, 2014, (6): 15-18. [8] Mann R D. Multi-criteria decision analysis-a new approach to an old problem[J]. Pharmacoepidemiology and Drug Safety, 2007, 16(S1):S1. [9] 何伟, 孙利华, 王秭萱, 等. 多准则决策分析用于国内外医疗保险报销项目评估情况分析[J]. 中国药物经济学, 2016, (5): 33-35. [10] Committee for Medical Products for Human Use. Benefit-risk methodology project: work package 2 report: applicability of current tools and processes for regulatory benefit-risk assessment[R]. London: European Medicines Agency, 2010:19. [11] Keeney R L, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Trade-Offs[M]//Preface to the Cambridge Press Edition. Cambridge: Cambridge University Press, 1993: xi-xiii. [12] Belton V, Stewart T. Multiple criteria decision analysis: an integrated approach[M]. Springer Science & Business Media, 2002. [13] Thokala P, Devlin N, Marsh K, et al. Multiple criteria decision analysis for health care decision making-an introduction: report 1 of the ISPOR MCDA Emerging Good Practices Task Force[J]. Value in health, 2016, 19(1): 1-13. [14] Marsh K, IJzerman M, Thokala P, et al. Multiple criteria decision analysis for health care decision making-emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force[J]. Value in health, 2016, 19(2): 125-137. [15] Marsh K, Lanitis T, Neasham D, et al. Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature[J]. Pharmacoeconomics, 2014, 32(4):345-65. [16] 周殿友. 优化后多准则决策分析模型用于药品效益风险评价的研究[D].太原: 山西医科大学, 2013. [17] Tervonen T, Lahdelma R. Implementing stochastic multicriteria acceptability analysis[J]. European Journal of Operational Research, 2007, 178(2): 500-513. |